VIDEREGEN LIMITED

Active Leeds

Other professional, scientific and technical activities n.e.c.

5 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
V

VIDEREGEN LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 22 Mar 2011 Active Leeds, England 5 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
Accounts Submitted 12 Aug 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 10 Apr 2026 Next due 5 Apr 2027 11 months remaining
Net assets £12K £697K 2024 year on year
Total assets £166K £630K 2024 year on year
Total Liabilities £154K £67K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Nexus Discovery Way University Of Leeds Leeds LS2 3AA England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for VIDEREGEN LIMITED (07573593), an active life sciences and medical technology company based in Leeds, England. Incorporated 22 Mar 2011. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£27.86k

Decreased by £510.35k (-95%)

Net Assets

£12.13k

Decreased by £696.75k (-98%)

Total Liabilities

£153.55k

Increased by £66.75k (+77%)

Turnover

N/A

Employees

5

Debt Ratio

93%

Increased by 82 (+745%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 5

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 3Sept 2014Seed
Investor 4Sept 2014Seed
Investor 1Jul 2015Seed

Share Capital

Share Capital

Share allotments and capital structure

37 Allotments 148,247 Shares £4.64m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Apr 20251,779£52k£29
4 Apr 20242,484£72k£29
31 Jan 20244,018£117k£29
1 Nov 2023285£8k£29
4 Apr 2023652£19k£29

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (32)

Kcp Nominees
39.4%
102,516
Nwf (biomedical) Lp
20.0%
52,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Deepbridge Capital Llp

United Kingdom

Active
Notified 24 Feb 2021
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Deepbridge Ned Limited

Unknown

Active
Notified 24 Feb 2021
Nature of Control
  • Significant Influence Or Control

Spark Impact Limited

Ceased 24 Feb 2021

Ceased

Group Structure

Group Structure

DEEPBRIDGE CAPITAL LLP united kingdom
VIDEREGEN LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026Confirmation StatementConfirmation statement made on 2026-03-22 with no updates
10 Apr 2026Persons With Significant ControlChange to Deepbridge Capital Llp as a person with significant control on 2026-03-01
2 Oct 2025Persons With Significant ControlChange to Deepbridge Capital Llp as a person with significant control on 2025-10-02
12 Aug 2025AccountsAnnual accounts made up to 2025-03-31
20 May 2025OfficersTermination of Stephen Bloor as director on 2025-05-20
10 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-03-22 with no updates

10 Apr 2026 Persons With Significant Control

Change to Deepbridge Capital Llp as a person with significant control on 2026-03-01

2 Oct 2025 Persons With Significant Control

Change to Deepbridge Capital Llp as a person with significant control on 2025-10-02

12 Aug 2025 Accounts

Annual accounts made up to 2025-03-31

20 May 2025 Officers

Termination of Stephen Bloor as director on 2025-05-20

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-22 with no updates

1 weeks ago on 10 Apr 2026

Change to Deepbridge Capital Llp as a person with significant control on 2026-03-01

1 weeks ago on 10 Apr 2026

Change to Deepbridge Capital Llp as a person with significant control on 2025-10-02

6 months ago on 2 Oct 2025

Annual accounts made up to 2025-03-31

8 months ago on 12 Aug 2025

Termination of Stephen Bloor as director on 2025-05-20

11 months ago on 20 May 2025